(Q77379022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

T P Degenhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M X Fu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E Voss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K Reiff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Neidlein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K Strein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S R Thorpe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J W Baynes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Reiter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

Diabetes Research and Clinical Practice

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

81-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Role of oxygen in cross-linking and chemical modification of collagen by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Pathways of Formation of Glycoxidation Products during Glycation of Collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Inhibition of in vivo histamine metabolism in rats by foodborne and pharmacologic inhibitors of diamine oxidase, histamine N-methyltransferase, and monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

The influence of aminoguanidine on borohydride reducible collagen cross-links and wound strength

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Effects of guanidino and uremic compounds on nitric oxide pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

Effects of aminoguanidine and pyridoxal phosphate on glycation reaction of aspartate aminotransferase and serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900121-1

7 January 2021

10.1016/S0168-8227(98)00121-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221660%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference